Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure - Results from the DCCT

被引:367
作者
Purnell, JQ
Hokanson, JE
Marcovina, SM
Steffes, MW
Cleary, PA
Brunzell, JD
机构
[1] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
[2] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA
[3] George Washington Univ, Ctr Biostat, Diabet Control & Complicat Trial Coordinating Ctr, Rockville, MD USA
[4] Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 280卷 / 02期
关键词
D O I
10.1001/jama.280.2.140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-Intensive treatment of type 1 diabetes results in greater weight gain than conventional treatment. Objective.-To determine the effect of this weight gain on lipid levels and blood pressure. Design.-Randomized controlled trial; ancillary study of the Diabetes Control and Complications Trial (DCCT). Setting.-Twenty-one clinical centers. Participants.-The 1168 subjects enrolled in DCCT with type 1 diabetes who were aged 18 years or older at baseline. Intervention.-Randomized to receive either intensive (n = 586) or conventional (n = 582) diabetes treatment with a mean follow-up of 6.1 years. Main Outcome Measures.-Plasma lipid levels and blood pressure in each treatment group categorized by quartile of weight gain. Results.-With intensive treatment, subjects in the fourth quartile of weight gain had the highest body mass index (BMI) (a measure of weight adjusted for height), blood pressure, and levels of triglyceride, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B compared with the other weight gain quartiles with the greatest difference seen when compared with the first quartile (mean values for the highest and lowest quartiles: BMI, 31 vs 24 kg/m(2); blood pressure, 120/77 mm Hg vs 113/73 mm Hg; triglyceride, 0.99 mmol/L vs 0.79 mmol/L [88 mg/dL vs 70 mg/dL]; LDL-C, 3.15 mmol/L vs 2.74 mmol/L [122 mg/dL vs 106 mg/dL]; and apolipoprotein B, 0.89 g/L vs 0.78 g/L; all P<.001). In addition, the fourth quartile group had a higher waist-to-hip ratio; more cholesterol in the very low density lipoprotein, intermediate dense lipoprotein, and dense LDL fractions; and lower high-density lipoprotein cholesterol and apolipoprotein A-I levels compared with the first quartile. Baseline characteristics were not different between the first and fourth quartiles of weight gain with intensive therapy except for a higher hemoglobin A,, in the fourth quartile. Weight gain with conventional therapy resulted in smaller increases in BMI, lipids, and systolic blood pressure. Conclusions.-The changes in lipid levels and blood pressure that occur with excessive weight gain with intensive therapy are similar to those seen in the insulin resistance syndrome and may increase the risk of coronary artery disease in this subset of subjects with time.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 27 条
[11]   Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women [J].
Gardner, CD ;
Fortmann, SP ;
Krauss, RM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11) :875-881
[12]   VARIATIONS IN INSULIN-STIMULATED GLUCOSE-UPTAKE IN HEALTHY-INDIVIDUALS WITH NORMAL GLUCOSE-TOLERANCE [J].
HOLLENBECK, C ;
REAVEN, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (06) :1169-1173
[13]   Cardiovascular disease and its risk factors in IDDM in Europe [J].
Koivisto, VA ;
Stevens, LK ;
Mattock, M ;
Ebeling, P ;
Muggeo, M ;
Stephenson, J ;
IdziorWalus, B ;
Karamanos, B ;
Tountas, C ;
Kofinis, A ;
Petrou, K ;
Katsilambros, N ;
Cignarelli, M ;
Giorgino, R ;
DeGeco, ML ;
Ramunni, I ;
IonescuTirgoviste, C ;
Iosif, CM ;
Pitei, C ;
Buligescu, S ;
Tamas, G ;
Kerenyi, Z ;
Ahmed, AM ;
Toth, J ;
Kempler, P ;
Muntoni, S ;
Songini, M ;
Stabilini, M ;
Fossarello, M ;
Pintus, S ;
Ferris, B ;
Cronin, CC ;
Toeller, M ;
Klischan, A ;
Forst, T ;
Gries, FA ;
Wagener, W ;
Rottiers, R ;
Priem, H ;
Sinisalo, M ;
Solnica, B ;
SzopinskaCiba, L ;
Solnica, K ;
Krans, M ;
Lemkes, HHPJ ;
Jansen, JJ ;
NunesCorrea, J ;
Rogado, C ;
Boavida, JM ;
Correia, LG .
DIABETES CARE, 1996, 19 (07) :689-697
[14]   MAGNITUDE AND DETERMINANTS OF CORONARY-ARTERY DISEASE IN JUVENILE-ONSET, INSULIN-DEPENDENT DIABETES-MELLITUS [J].
KROLEWSKI, AS ;
KOSINSKI, EJ ;
WARRAM, JH ;
LELAND, OS ;
BUSICK, EJ ;
ASMAL, AC ;
RAND, LI ;
CHRISTLIEB, AR ;
BRADLEY, RF ;
KAHN, CR .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (08) :750-755
[15]   INCREASING PREVALENCE OF OVERWEIGHT AMONG US ADULTS - THE NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEYS, 1960 TO 1991 [J].
KUCZMARSKI, RJ ;
FLEGAL, KM ;
CAMPBELL, SM ;
JOHNSON, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (03) :205-211
[16]   ADVERSE-EFFECTS OF OBESITY ON LIPID AND LIPOPROTEIN LEVELS IN INSULIN-DEPENDENT AND NON INSULIN-DEPENDENT DIABETES [J].
LAAKSO, M ;
PYORALA, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (02) :117-122
[17]  
MARCOVINA SM, 1995, CLIN CHEM, V41, P246
[18]  
MARCOVINA SM, 1994, CLIN CHEM, V40, P586
[19]  
*METR LIF INS CO, 1993, STAT B METR LIF INC, V43, P410
[20]   LEVELS OF LIPOPROTEIN(A), APOLIPOPROTEIN-B, AND LIPOPROTEIN CHOLESTEROL DISTRIBUTION IN IDDM - RESULTS FROM FOLLOW-UP IN THE DIABETES CONTROL AND COMPLICATIONS TRIAL [J].
PURNELL, JQ ;
MARCOVINA, SM ;
HOKANSON, JE ;
KENNEDY, H ;
CLEARY, PA ;
STEFFES, MW ;
BRUNZELL, JD .
DIABETES, 1995, 44 (10) :1218-1226